AXIM - AXIM Biotechnologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
680
196
48
47
Cost of Revenue
420
9
43
154
Gross Profit
260
187
5
-107
Operating Expenses
Research Development
2,305
2,056
1,353
236
Selling General and Administrative
3,927
3,164
1,797
3,413
Total Operating Expenses
6,236
5,223
3,154
3,652
Operating Income or Loss
-5,975
-5,036
-3,149
-3,759
Interest Expense
454
1,579
315
276
Total Other Income/Expenses Net
439
-140
-706
-1,775
Income Before Tax
-5,990
-6,755
-4,168
-5,810
Income Tax Expense
0
0
0
0
Income from Continuing Operations
-5,990
-6,755
-4,168
-5,810
Net Income
-5,990
-6,755
-4,168
-5,810
Net Income available to common shareholders
-5,990
-6,755
-4,168
-7,285
Reported EPS
Basic
-
-0.12
-0.08
-0.17
Diluted
-
-0.12
-0.08
-0.17
Weighted average shares outstanding
Basic
-
57,284
53,296
41,732
Diluted
-
57,284
53,296
41,732
EBITDA
-
-5,163
-3,850
-5,531